» Articles » PMID: 24450636

Structures of Soluble Guanylate Cyclase: Implications for Regulatory Mechanisms and Drug Development

Overview
Specialty Biochemistry
Date 2014 Jan 24
PMID 24450636
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of cGMP synthesis leads to vasodilation, and is an important mechanism in clinical treatment of angina, heart failure, and severe peripheral and pulmonary hypertension. The nitric oxide-responsive sGC (soluble guanylate cyclase) has been the target of recent drug discovery efforts. The present review surveys recent data on the structure and regulation of sGC, and the prospects of new avenues for therapeutic intervention.

Citing Articles

The evolution of small molecule enzyme activators.

Dow L, Case A, Paustian M, Pinkerton B, Simeon P, Trippier P RSC Med Chem. 2023; 14(11):2206-2230.

PMID: 37974956 PMC: 10650962. DOI: 10.1039/d3md00399j.


The role of activation of two different sGC binding sites by NO-dependent and NO-independent mechanisms in the regulation of SACs in rat ventricular cardiomyocytes.

Kamkin A, Kamkina O, Shim A, Bilichenko A, Mitrokhin V, Kazansky V Physiol Rep. 2022; 10(7):e15246.

PMID: 35384354 PMC: 8981922. DOI: 10.14814/phy2.15246.


Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer.

Di Iorio P, Ronci M, Giuliani P, Caciagli F, Ciccarelli R, Caruso V Int J Mol Sci. 2022; 23(1).

PMID: 35008687 PMC: 8745278. DOI: 10.3390/ijms23010262.


Guanylyl Cyclase-cGMP Signaling Pathway in Melanocytes: Differential Effects of Altered Gravity in Non-Metastatic and Metastatic Cells.

Ivanova K, Hemmersbach R Int J Mol Sci. 2020; 21(3).

PMID: 32046325 PMC: 7037284. DOI: 10.3390/ijms21031139.


cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging.

Bork N, Nikolaev V Int J Mol Sci. 2018; 19(3).

PMID: 29534460 PMC: 5877662. DOI: 10.3390/ijms19030801.


References
1.
Duda T, Yadav P, Sharma R . ATP allosteric activation of atrial natriuretic factor receptor guanylate cyclase. FEBS J. 2010; 277(11):2550-3. PMC: 2916748. DOI: 10.1111/j.1742-4658.2010.07670.x. View

2.
Rauch A, Leipelt M, Russwurm M, Steegborn C . Crystal structure of the guanylyl cyclase Cya2. Proc Natl Acad Sci U S A. 2008; 105(41):15720-5. PMC: 2572937. DOI: 10.1073/pnas.0808473105. View

3.
Robinson J, Potter L . Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain. Sci Signal. 2012; 5(240):ra65. PMC: 4411398. DOI: 10.1126/scisignal.2003253. View

4.
Schmidt P, Schramm M, Schroder H, Stasch J . Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur J Pharmacol. 2003; 468(3):167-74. DOI: 10.1016/s0014-2999(03)01674-1. View

5.
Ghofrani H, Galie N, Grimminger F, Grunig E, Humbert M, Jing Z . Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013; 369(4):330-40. DOI: 10.1056/NEJMoa1209655. View